Trials / Completed
CompletedNCT05211193
Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).
Open Label, Multi Center Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous NeuroModulation (eTNM) Treatment Via Nerve Stimulator URIS I (Tesla Medical) in the Treatment of Overactive Bladder (OAB).
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Stimvia s.r.o. · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Open label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous NeuroModulation (eTNM) Treatment Via Nerve Stimulator URIS I in the Treatment of Overactive Bladder.
Detailed description
Open label, Multi center Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous NeuroModulation (eTNM) Treatment Via Nerve Stimulator URIS I in the Treatment of Overactive Bladder (OAB).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | eTNM delivered by URIS I nerve stimulation device | eTNM delivered by URIS I nerve stimulation device, self administered in the subject's home for 30 minutes per day, for a minimum of 34 therapy session between day 1-42. |
Timeline
- Start date
- 2020-01-08
- Primary completion
- 2020-04-28
- Completion
- 2020-11-02
- First posted
- 2022-01-27
- Last updated
- 2022-02-17
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT05211193. Inclusion in this directory is not an endorsement.